[Nitrobenzofuroxane derivatives as dual action hiv-1 inhibitors]. / Proizvodnye nitrobenzofuroksanov v kachestve ingibitorov VICh-1 dvoinogo deistviia.
Biomed Khim
; 62(6): 725-728, 2016 Nov.
Article
en Ru
| MEDLINE
| ID: mdl-28026819
Human immunodeficiency virus first type (HIV-1) is a main cause of one of the most dangerous diseases, AIDS. The search for new inhibitors of the virus still remains an urgent task. One approach to suppress the HIV infection is to use a double-acting inhibitors, i.e. inhibitors directed to two stages of the viral life cycle. The catalytic domain of HIV-1 integrase has a similar spatial organization with ribonuclease (RNase H) domain of HIV-1 reverse transcriptase, and approach aimed to create HIV-1 integrase and RNase H double-acting is very promising. In this work we synthesized a series of 6-nitrobenzofuroxane derivatives and studied their ability to inhibit two viral enzymes - integrase and RNase H HIV-1.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Oxadiazoles
/
VIH-1
/
Inhibidores de la Transcriptasa Inversa
/
Transcriptasa Inversa del VIH
Límite:
Humans
Idioma:
Ru
Revista:
Biomed Khim
Año:
2016
Tipo del documento:
Article
País de afiliación:
Rusia
Pais de publicación:
Rusia